APA (7th ed.) Citation

Zhang, Z., Huang, W., Huang, D., Xu, Z., Xie, Q., Tan, X., . . . Liu, H. (2025). Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription. Communications Biology, 8(1), 1. https://doi.org/10.1038/s42003-025-07519-9

Chicago Style (17th ed.) Citation

Zhang, Zhenzhan, et al. "Repurposing of Phosphodiesterase-5 Inhibitor Sildenafil as a Therapeutic Agent to Prevent Gastric Cancer Growth Through Suppressing C-MYC Stability for IL-6 Transcription." Communications Biology 8, no. 1 (2025): 1. https://doi.org/10.1038/s42003-025-07519-9.

MLA (9th ed.) Citation

Zhang, Zhenzhan, et al. "Repurposing of Phosphodiesterase-5 Inhibitor Sildenafil as a Therapeutic Agent to Prevent Gastric Cancer Growth Through Suppressing C-MYC Stability for IL-6 Transcription." Communications Biology, vol. 8, no. 1, 2025, p. 1, https://doi.org/10.1038/s42003-025-07519-9.